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Abstract
Background: Among all known picornaviruses, only two species, equine rhinitis A virus and equine rhinitis B virus
(ERBV) are known to infect horses, causing respiratory infections. No reports have described the detection of ERBV
in fecal samples of horses and no complete genome sequences of ERBV3 are available.
Methods: We performed a molecular epidemiology study to detect ERBVs in horses from Dubai and Hong Kong.
Complete genome sequencing of the ERBVs as well as viral loads and genome, phylogenetic and evolutionary
analysis were performed on the positive samples.
Results: ERBV was detected in four (13.8 %) of the 29 fecal samples in horses from Dubai, with viral loads 8.28 × 103
to 5.83 × 104 copies per ml, but none of the 47 fecal samples in horses from Hong Kong by RT-PCR. Complete
genome sequencing and phylogenetic analysis showed that three of the four strains were ERBV3 and one was
ERBV2. The major difference between the genomes of ERBV3 and those of ERBV1 and ERBV2 lied in the amino acid
sequences of their VP1 proteins. The Ka/Ks ratios of all the coding regions in the ERBV3 genomes were all <0.1,
suggesting that ERBV3 were stably evolving in horses. Using the uncorrelated lognormal distributed relaxed clock
model on VP1 gene, the date of the most recent common ancestor (MRCA) of ERBV3 was estimated to be 1785
(HPDs, 1176 to 1937) and the MRCA dates of ERBV1 and ERBV2 were estimated to be 1848 (HPDs, 1466 to 1949)
respectively.
Conclusions: Both acid stable (ERBV3) and acid labile (ERBV2) ERBVs could be found in fecal samples of horses.
Detection of ERBVs in fecal samples would have implications for their transmission and potential role in
gastrointestinal diseases as well as fecal sampling as an alternative method of identifying infected horses.
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Background
Picornaviruses are widely distributed in human and vari-
ous animals in which they can cause respiratory, cardiac,
hepatic, neurological, mucocutaneous and systemic dis-
eases of varying severity [1]. Based on genotypic and
serological characterization, the family Picornaviridae is
currently divided into 26 genera. Among all the known
picornaviruses, only two species, namely equine rhinitis
A virus (ERAV) and equine rhinitis B virus (ERBV) are
known to infect horses. ERAV, formerly called equine
rhinovirus 1, belongs to the genus Aphthovirus; whereas
ERBV, further subclassified into three serotypes, includ-
ing ERBV1 and ERBV2 which are acid labile and were
previously known as equine rhinovirus 2 and 3 respect-
ively, and ERBV3 which was previously called acid-stable
equine picornavirus, is the only species of a recently cre-
ated species of the genus Erbovirus [2].
Both ERAV and ERBV are associated with respiratory
diseases in horses and are therefore primarily found in
nasal, nasopharyngeal and oral secretions [3–6]. Infected
horses develop fever, anorexia, nasal discharge, cough
and lymphadenitis. These respiratory diseases in horses
are of particular importance because of their effect on
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the performance horse industry and they are also an
economic burden for the horse owners. Sometimes
ERAV can also be detected in plasma and urine [7,
8]. Although one study has reported the isolation of
ERAV from the fecal samples of 13 out of 290 horses
more than 50 years ago [9], so far no reports have
described the detection of ERBV in fecal samples of
horses. Since it is well-known that some respiratory
picornaviruses, such as rhinoviruses [10], can be de-
tected in fecal samples of infected individuals, we
hypothesize that ERBV may be detectable in fecal
samples of horses. This would have implications for
transmission of the viruses, their potential role in
gastrointestinal diseases and fecal sampling as an al-
ternative method of identifying infected animals. To
test this hypothesis, we performed a molecular epidemi-
ology study on horses from Dubai and Hong Kong,
two cities with the most popular horse racing indus-
tries. Comparative genomics of the complete genomes
of ERBVs observed in fecal samples of the present
study and the only two previously published complete
genomes of ERBV1 and ERBV2 isolated from the
nasal samples of horses were also performed.
Results
Horse surveillance and identification of ERBV
RT-PCR for a 111-bp fragment in the 5’-UTR of picor-
naviruses was positive in specimens from the fecal sam-
ples of four (13.8 %) of 29 horses from Dubai. The
sequences from these positive samples had 89–95 % and
90-94 % nucleotide identities to the corresponding parts
of the 5’-UTR in ERBV1 and ERBV2 respectively, sug-
gesting the presence of ERBV in fecal samples of horses
(Fig. 1a). On the other hand, none of the 47 fecal sam-
ples of horses from Hong Kong was positive.
Real-time quantitative RT-PCR
Real-time quantitative RT-PCR showed that the amount
of ERBV RNA in the four positive samples ranged from
8.28 × 103 to 5.83 × 104 copies per ml of fecal sample
(Table 1).
Genome organization and coding potential
The complete genomes of the four strains of ERBVs
(strains 303, 396, 421 and 1228) were sequenced and as-
sembled. The size of the four genomes ranged from
8823 to 8831 bases, after excluding the polyadenylated
tract; and the G + C content ranged from 49.5 to 50.3 %
(Table 2). Each genome contained a large open reading
frame of 7752 (strain 1228) or 7764 (strains 303, 396
and 421) bases, which encoded potential polyprotein
precursors of 2584 (strain 1228) or 2588 (strains 303,
396 and 421) amino acids. The genome organization was
similar to other picornaviruses, with the characteristic
gene order 5’-VP4, VP2, VP3, VP1, 2A, 2B, 2C, 3A, 3B,
3Cpro, 3Dpol-3’. The hypothetical protease cleavage sites
of the polyproteins, as determined by multiple align-
ments with the only two available complete genomes of
ERBV1 and ERBV2, were analyzed (Table 3). The amino
acids of strain 1228 at all the putative cleavage sites were
identical to those of the two genomes of ERBV1 and
ERBV2, whereas those of strains 303, 396 and 421 at all
(See figure on previous page.)
Fig. 1 a Phylogenetic analysis of nucleotide sequences of the 73-bp fragment (excluding primer sequences) of the partial 5’ UTR of the ERBV
detected from four fecal samples of horses in the present study. The four strains with genomes completely sequenced are shaded in gray. The
trees were constructed by the neighbor-joining method, and bootstrap values calculated from 1000 trees. Bootstrap values expressed as
percentages are shown at nodes and only those >70 % are shown. The scale bar indicates the estimated number of substitutions per 20
nucleotides. Phylogenetic analyses of the (b) P1, (c) VP1, (d) P2, and (e) P3 regions of the four ERBVs (shaded in gray) in the present study and
those of other ERBVs. ERAV was included as the outgroup. The scale bars indicate the estimated number of substitutions per 10 (P1), 5 (VP1) and
10 (P2) and 10 (P3) amino acids, respectively. Virus abbreviations (GenBank accession numbers shown in parentheses): AEV, avian encephalomyelitis
virus (NC_003990); AiV, Aichi virus A (NC_001918); BHUV1, Hunnivirus A (NC_018668); CPDV-209, Cadicivirus A (JN819202); DHAV-1, duck hepatitis A
virus 1 (NC_008250); DPV, avian sapelovirus (NC_006553); EMCV, encephalomyocarditis virus (NC_001479); ERAV, equine rhinitis A virus (NC_003982);
ERBV strains, 1576/99 (AY606998), 2225AS (GU799328), 2484c/75 (DQ108385), 263/75 (AY606990), 271AL (GU799329), 271AS (GU799330), 271/75
(AY606991), 293/74 (AY606988), 322/74 (AY606989), 379AL (GU799331), 379/75 (AY606992), 4442/75 (DQ108383), 57-14/89 (AY606994), 58-13/89
(AY606995), 83-11/89 (AY606996), 9051-7/89 (AY606997), KP/92 (AY606993), R4/75 (DQ108384); ERBV1, equine rhinitis B virus 1 (NC_003983); ERBV2,
equine rhinitis B virus 2 (AF361253); EV-C, Enterovirus C (NC_002058); FMDV-O, foot-and-mouth disease virus type O (NC_004004); HAV, hepatitis A virus
(NC_001489); HCoSV-A1, Cosavirus A (NC_012800); HPeV, human parechovirus (NC_001897); MsPV1, Mischivirus A (JQ814851); MoV, Mosavirus A
(NC_023987); PTV-1, porcine teschovirus (NC_003985); RosaV, Rosavirus A (JF973686); SaV, Salivirus A (NC_012957); SePV1, Aquamavirus A (NC_009891);
SwPV1, Swine pasivirus 1 (NC_018226); SVV, Seneca Valley virus (NC_011349); TV1, Passerivirus A (NC_014411); TV2, Oscivirus A (NC_014412); TuASV,
Avisivirus A (KC465954); TuGV, Gallivirus A (NC_018400); THV-2993D, Megrivirus A (HM751199)
Table 1 Viral load of ERBV in fecal samples
Sample number Specimen collection
date
Serotype Concentration of
ERBV (copies/ml)
303 April 2013 ERBV3 5.48 × 104
396 June 2013 ERBV3 1.22 × 104
421 June 2013 ERBV3 5.83 × 104
1228 May 2014 ERBV2 8.28 × 103
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the cleavage sites, except VP1/2A, were identical to
those in the two ERBV1 and ERBV2 genomes [11, 12].
Phylogenetic analyses
The phylogenetic trees constructed using the amino acid
sequences of P1, VP1, P2 and P3 of the ERBV strains
from this study and other erboviruses are shown in
Fig. 1b, c, d and 1e respectively and the corresponding
pairwise amino acid identities are shown in Table 2. For
the trees constructed using P1 and VP1, strains 303, 396
and 421 were clustered with other strains of ERBV3,
whereas strain 1228 was clustered with other strains of
ERBV2, with high bootstrap supports. Correspondingly,
these two regions of strains 303, 396 and 421 possessed
significantly lower amino acid identities to the P1 and
VP1 regions of ERBV1 and ERBV2 than to those of
ERBV3 (Table 2). On the other hand, strain 1228 pos-
sessed significantly lower amino acid identities to the P1
and VP1 regions of ERBV1 and ERBV3 than to those of
ERBV2 (Table 2). As for P2 and P3, the amino acid se-
quences of ERBV1, ERBV2 and the ERBV strains in the
present study showed high identities of 96.3–97.7 %
(Table 2), and therefore were indistinguishable from
each other (Fig. 1).
Genome analyses of ERBV3
Since no ERBV3 genome sequences were available and
three (strains 303, 396 and 421) of the four strains were
ERBV3, we further analyzed these three ERBV3 genomes
and compared them with those of ERBV1 and ERBV2.
Similar to ERBV1 and ERBV2, the 5’ UTR of ERBV3
contained a polypyrimidine tract and 15 downstream
stem-loop structures forming six domains (domains G
to L) and demonstrated the conserved characteristics of
a type II internal ribosome entry site (IRES) element.
Domain G formed a stem-loop structure. Domains H, I,
J, K and L are the main domains of the IRES element,
responsible for directing the initiation of translation in a
cap-independent manner, which requires both canonical
translation initiation and IRES trans-acting factors [13].
Domain I was divided into sub-domains Ia, Ib and Ic.
Domain Ib contained the characteristic tetra-loop con-
formation and conserved GNRA motifs. Upstream to
the AUG start codon, the Yn-Xm-AUG motif was
present at domain L (Fig. 2). Similar to other erbo-
viruses, there was an L protein in the polyprotein of
ERBV3 with putative protease activity.
The P1 (capsid-coding) regions in the genomes of
ERBV3 encoded the capsid genes VP4, VP2, VP3 and
VP1. Similar to ERBV1 and ERBV2, the cleavage sites at
the junction of VP4/VP2, VP2/VP3 and VP3/VP1 in the
three genomes of ERBV3 were Leu/Asp, Glu/Gly and
Glu/Gly respectively. However, the cleavage sites of the
three ERBV3 genomes at the cleavage junction of VP1/
2A were Ser/Asn, whereas those of ERBV1 and ERBV2
as well as strain 1228 were Thr/Asn. Like ERBV1 and
ERBV2, all the three ERBV3 genomes did not possess
the [PS]ALXAXETG motif.
The P2 regions in the three ERBV3 genomes encoded
non-structural proteins 2A, 2B and 2C. The 2A protein
Table 2 Comparison of genomic features of the four strains of ERBVs in the present study and ERBV1 and ERBV2 and the amino
acid identities between their predicted P1, VP1, P2 and P3
Virus Accession no. Genome features Pairwise amino acid identity (%)
Size G + C Strain 303 Strain 396 Strain 421 Strain 1228
(bases) content P1 VP1 P2 P3 P1 VP1 P2 P3 P1 VP1 P2 P3 P1 VP1 P2 P3
ERBV1 NC_003983 8828 0.49 78.0 69.4 97.4 96.8 78.1 69.8 96.6 97.4 77.7 69.8 98.1 97.6 73.0 66.7 97.9 96.3
ERBV2 AF361253 8821 0.50 74.8 63.3 98.1 97.7 74.9 63.8 97.4 97.5 74.3 63.4 98.1 97.0 95.3 95.3 98.4 96.7
ERBV3a DQ108385 - - 93.3 88.2 - - 94.3 91.6 - - 95.3 92.6 - - 74.7 62.3 - -
Strain 303 KX260138 8828 0.50 - - - - 94.2 88.5 97.9 98.7 94.4 90.1 98.1 98.1 75.7 64.2 98.7 97.8
Strain 396 KX260139 8831 0.50 94.2 88.5 97.9 98.7 - - - - 95.2 92.6 97.6 98.6 75.1 63.5 97.9 98.2
Strain 421 KX260140 8830 0.50 94.4 90.1 98.1 98.1 95.2 92.6 97.6 98.6 - - - - 75.0 64.0 98.2 97.5
Strain 1228 KX260141 8823 0.50 75.7 64.2 98.7 97.8 75.1 63.5 97.9 98.2 75.0 64.0 98.2 97.5 - - - -
aOnly P1 region is available
Table 3 Coding potential of four strains of ERBVs in the present
study
Putative proteins Strain 303 Strain 396 Strain 421 Strain 1228
L M1-R219 M1-R219 M1-R219 M1-R219
VP4 G220-L290 G220-L290 G220-L290 G220-L289
VP2 D291-E546 D291-E546 D291-E546 D290-E545
VP3 G547-E775 G547-E775 G547-E775 G546-E775
VP1 G776-S1098 G776-S1098 G776-S1098 G776-T1094
2A N1099-G1114 N1099-G1114 N1099-G1114 N1095-G1110
2B P1115-E1397 P1115-E1397 P1115-E1397 P1111-E1393
2C G1398-Q1714 G1398-Q1714 G1398-Q1714 G1394-Q1710
3A S1715-S1847 S1715-S1847 S1715-S1847 S1711-S1843
3B R1848-E1868 R1848-E1868 R1848-E1868 R1844-E1864
3C N1869-Q2120 N1869-Q2120 N1869-Q2120 N1865-Q2116
3D G2121-L2588 G2121-L2588 G2121-L2588 G2117-L2584
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of picornaviruses is a highly variable region (9 to 305
amino acids). Similar to ERBV1 and ERBV2, the 2A pro-
teins of ERBV3 was 16 amino acids in length and con-
tained the Asn-Pro-Gly-Pro (NPGP) motif required for
co-translational cleavage [14]. The 2A protein of ERBV3
exhibited 87.5–100 % amino acid identities to those of
ERBV1 and ERBV2. The 2A protein shared 93.8 %
amino acid identities among the three ERBV3 strains.
Similar to ERBV1 and ERBV2, the 2A of ERBV3 did not
possess the chymotrypsin-like structures with cysteine-
reactive catalytic sites and the conserved GXCG motif
found in the 2A proteinases of enteroviruses and rhino-
viruses [14, 15]. The conserved H-box/NC motif, ob-
served in members of the genera Avihepatovirus,
Kobuvirus, Tremovirus and Passerivirus that was in-
volved in cell proliferation control, was also absent [15–
17]. Similar to most picornaviruses, the 2C of ERBV3
possessed the GXXGXGKS motif for NTP-binding [18]
and DDLXQ for helicase activity [19].
The P3 regions in the three ERBV3 genomes encoded
3A, 3B (VPg, small genome-linked protein), 3Cpro (pro-
tease) and 3Dpol (RNA-dependent RNA polymerase).
Similar to the 3Cpro of ERBV1 and ERBV2, the catalytic
triad of the 3Cpro of ERBV3 was His-Asp-Cys. This was
different from the 3Cpro of picornaviruses of some other
genera, such as Enterovirus, Sapelovirus and Kobuvirus,
which have catalytic triads of His-Glu-Cys. Similar to
most picornaviruses, ERBV3 also contained the con-
served GXCG and GXH motifs which form part of the
active site of the protease. Similar to ERBV1 and ERBV2,
ERBV3 did not possess the conserved RNA-binding
motif KFRDI [20, 21]. Similar to other picornaviruses,
the 3Dpol of ERBV3 contained the conserved KDE[LI]R,
YGDD and FLKR motifs [22]. Similar to ERBV1 and
ERBV2, ERBV3 possessed the GALPSG motif, instead of
GG[LMN]PSG as in the genera Aphthovirus, Cardio-
virus, Enterovirus, Kobuvirus, Parechovirus, Sapelovirus,
Senecavirus and Teschovirus, in the 3Dpol.
Estimation of synonymous and non-synonymous substitu-
tion rates
Using the three ERBV3 genome sequences for analysis,
the Ka/Ks ratios for the various coding regions were cal-
culated (Table 4). All Ka/Ks ratios were all <0.1, suggest-
ing that ERBV3 was stably evolving in horses.
Estimation of divergence dates
Using the uncorrelated lognormal distributed relaxed
clock model (UCLD) [23] on VP1 gene, the date of the
most recent common ancestor (MRCA) of ERBV3 was
estimated to be 1785 (HPDs, 1176 to 1937), approxi-
mately 230 years before the present (Fig. 3). Moreover,
the MRCA dates of ERBV1 and ERBV2 were estimated
to be 1848 (HPDs, 1466 to 1949) and 1847 (HPDs, 1421
to 1963), approximately 167 and 168 years before the
present, respectively (Fig. 3). The estimated mean substi-
tution rate of the VP1 data set under the UCLD model
was 2.09 × 10−3 substitution per site per year.
Fig. 2 Secondary structure of predicted IRES in ERBV3 strain 303. The Yn-Xm-AUG motif is labeled
Table 4 Synonymous and non-synonymous substitution rates
of each coding region among the three genomes of ERBV
Putative proteins No. of amino acids Ka Ks Ka/Ks
L 219 0.0485 1.5837 0.0316
VP4 70–71 0.0146 1.6845 0.0074
VP2 256 0.0279 0.0000 -
VP3 229–230 0.0213 1.7612 0.0122
VP1 319–323 0.0792 2.2486 0.0363
2A 16 0.0692 1.3160 0.0728
2B 283 0.0233 1.4797 0.0177
2C 317 0.0106 0.9440 0.0113
3A 133 0.0231 0.9593 0.0242
3B 21 0.0294 0.6540 0.0639
3C 252 0.0126 0.6211 0.0203
3D 468 0.0038 0.2511 0.0152
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Discussion
We report the first discovery of ERBVs in fecal samples
of horses. Although both ERBV1 and ERBV2 have been
found to be present in horses globally [24–29], so far
ERBV3 has only been reported from horses in Australia,
Japan and the United Kingdom [30–32] and no ERBVs
have been detected in fecal samples. In the present
study, ERBVs were observed in fecal samples of horses
in Dubai. Phylogenetic analysis showed that one and
three of the four strains were ERBV2 and ERBV3 re-
spectively. Although the relatively higher chance of de-
tecting ERBV3 in fecal samples may be related to its
acid stability, the property does not exclude the presence
of acid labile serotypes in stools. The observation of
ERBVs in fecal samples of horses is analogous to infec-
tions by some other respiratory viruses, such as influ-
enza virus, SARS coronavirus, rhinovirus and bocavirus,
which have also been detected in the fecal samples of
patients with infections by these viruses [10, 33–35]. For
example, in our previous study on picornaviruses in fecal
samples of children, human rhinovirus C was detected
in four of 734 fecal samples from children with gastro-
enteritis [10]. Among these four children, three did not
have any respiratory symptoms. Although detection of
ERBVs in fecal samples by RT-PCR does not confirm
infection of the gastrointestinal tract, such detection of
ERBVs in fecal samples has direct implications for the
infection control measures of infected horses. In
addition to respiratory droplets, ERBVs may also spread
through the feces of the horses. So far, the cellular re-
ceptors for ERBVs are unknown [36]. Further studies are
required to examine if ERBVs could be associated with
gastroenteritis or other gastrointestinal diseases in
horses.
In addition to the first descriptions of ERBVs in equine
fecal samples and ERBV3 in horses of the Middle East,
this study also presents the first complete genome se-
quences of ERBV3. The genomes of ERBV1 and ERBV2
were sequenced in 1996 and 2001 respectively [11, 12].
On the other hand, only P1 sequences of ERBV3 were
available. In this study, we sequenced three complete ge-
nomes of ERBV3. Similar to ERBV1 and ERBV2, ERBV3
also possesses a type II IRES element and most of the
characteristic motifs in the various proteins encoded by
the ERBV1 and ERBV2 genomes are also present in the
ERBV3 genomes. The genome size of ERBV3 is compar-
able to those of ERBV1 and ERBV2, and collectively
these genomes are some of the largest ones in the family
Picornaviridae. The exceptionally large genome size of
ERBV1, ERBV2 and ERBV3 is due to their long 5’-UTR
Fig. 3 Estimation of tMRCA of ERBV1, ERBV2 and ERBV3 based on the VP1 gene. The mean estimated dates are labeled. The taxa are labeled with
their sampling years
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Fig. 4 Multiple alignment of amino acid sequences from VP1 of 24 ERBVs. Positions at which ERBV3 is different from ERBV1 and ERBV2 strains are
highlighted. Gaps introduced to maximize alignment are indicated by dashes. Conserved amino acids are indicated by an asterisk below the
sequence alignment. Clustalw was used for the multiple alignments
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and VP1. Their 5’-UTR are particularly long because of
the characteristic presence of polypyrimidine tract up-
stream to their type II IRES. The low Ka/Ks ratio of all
coding regions of the ERBV3 genomes showed that the
virus is stably evolving in horses, supporting that horses
are the natural reservoir of ERBV3. Since the P2 and P3
of ERBV1, ERBV2 and ERBV3 possess very high amino
acid identities and are indistinguishable from each other,
sequencing of P1, particularly its VP1 region, would be
necessary for distinguishing among these three serotypes
of ERBV.
The mechanism of acid stability in ERBVs remains to
be determined. ERBV1 and ERBV2 are inherently acid
labile, whereas ERBV3 is inherently acid stable and is
able to survive at pH 3.3 [32]. Since it has been shown
that the VP1 amino acid sequences of ERBV3 form a
distinct cluster from those of ERBV1 and ERBV2 and
the C-terminal of VP1 is the most exposed part of the
virus, it is believed that the VP1 is responsible for acid
stability of ERBV3 [37, 38]. In the present study, with
the availability of the ERBV3 complete genomes, we
confirmed the major difference between the genome se-
quences of ERBV3 and those of ERBV1 and ERBV2 lies
in the amino acid sequences of their VP1 proteins. In a
previous experiment, it has been shown that the acid
stability of eight ERBV1 mutants induced by incubating
an ERBV1 strain at lower pH can be increased and the
viruses can survive at pH 4.0 but not pH 3.3 [31]. P1 se-
quencing of these eight ERBV1 mutants revealed a single
nucleotide change at nucleotide position 901 (U→ C) of
VP1, leading to an amino acid change from tyrosine to
histidine. In the genomes of ERBV3, this position is oc-
cupied by valine, arginine or lysine. In the ERBV2 gen-
ome from fecal sample in the present study as well as
the only one ERBV2 genome from nasal sample, this
amino acid at this position of their P1 sequences was
not found (Fig. 4). Notably, there are other amino acid
positions where the ERBV3 strains are different from the
ERBV1 and ERBV2 strains (Fig. 4), although no muta-
genesis studies have been carried out to determine their
importance for acid stability. For example, position 201
are occupied by lysine in ERBV3 but valine and histidine
in ERBV1 and ERBV2 respectively, and position 284 or
285 is occupied by proline in ERBV1 and ERBV2 but no
amino acid is observed at this position in ERBV3 (Fig. 4).
Therefore, it is still inconclusive on which amino acid(s)
of the VP1 in ERBV3 are the most important for its acid
stability and further experiments are still required to de-
termine this.
Conclusions
Both acid stable (ERBV3) and acid labile (ERBV2) ERBVs
could be found in fecal samples of horses. Detection of
ERBVs in fecal samples would have implications for their
transmission and potential role in gastrointestinal dis-
eases as well as fecal sampling as an alternative method
of identifying infected horses.
Methods
Horse surveillance and sample collection
All equine fecal samples from Dubai were left-over spec-
imens submitted for pathogens screening to Central Vet-
erinary Research Laboratory in Dubai, United Arab
Emirates (UAE) from April 2013 to July 2014 because of
routine check-up, diarrhea or weight loss. A total of 29
fecal samples had been tested. All equine fecal samples
from Hong Kong were collected from horses of The
Hong Kong Jockey Club because of fever. A total of 47
fecal samples had been collected and tested from No-
vember 2010 to April 2011.
RNA extraction
Viral RNA was extracted from the fecal samples using
EZ1 Virus Mini Kit v2.0 (Qiagen, Hilden, Germany).
The RNA was eluted in 60 μl of AVE buffer (Qiagen,
Hilden, Germany) and was used as the template for
RT-PCR.
RT-PCR of 5’-untranslated region (UTR) of picornaviruses
using conserved primers and DNA sequencing
Initial picornavirus screening was performed by amplify-
ing a 111-bp fragment of the 5’-UTR of Erbovirus using
primers (5’-GCTAAGGATGYCCTWCAGGT-3’ and 5’-
GGCATAGAMGYTTTTTAAAC-3’) targeting con-
served sequences of Erbovirus. Reverse transcription was
performed using the SuperScript III kit (Invitrogen, San
Diego, CA, USA) [17, 39–44] and the reaction mixture
(10 μl) contained RNA, first-strand buffer (50 mM Tris–
HCl pH 8.3, 75 mM KCl, 3 mM MgCl2), 5 mM DTT,
50 ng random hexamers, 500 μM of each dNTPs and
100 U Superscript III reverse transcriptase. The mixtures
were incubated at 25 °C for 5 min, followed by 50 °C for
60 min and 70 °C for 15 min. The PCR mixture (25 μl)
contained cDNA, PCR buffer (10 mM Tris–HCl pH 8.3,
50 mM KCl, 2 mM MgCl2 and 0.01 % gelatin), 200 μM
of each dNTPs and 1.0 U Taq polymerase (Applied Bio-
system, Foster City, CA, USA). The mixtures were amp-
lified in 60 cycles of 94 °C for 1 min, 55 °C for 1 min
and 72 °C for 1 min and a final extension at 72 °C for
10 min in an automated thermal cycler (Applied Biosystem,
Foster City, CA, USA) [45–47]. Standard precautions were
taken to avoid PCR contamination and no false-positive
was observed in negative controls.
All PCR products were gel-purified using the QIA-
quick gel extraction kit (QIAgen, Hilden, Germany).
Both strands of the PCR products were sequenced
twice with an ABI Prism 3730xl DNA Analyzer (Applied
Biosystems, Foster City, CA, USA), using the two PCR
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primers. The sequences of the PCR products were com-
pared with known sequences of the 5’-UTR of picornavi-
ruses in the GenBank database.
Real-time quantitative RT-PCR
Real-time quantitative RT-PCR to detect the 3Dpol of
ERBV was performed on the four positive fecal samples
by the use of Premix Ex Taq™ (Probe qPCR) (TaKaRa,
Japan) with primers 5’- TAATCAGCCACTGCCTCT-3’
and 5’-GAAACACAACGTCTGCCAA-3’ and probe 5’-
6FAM-ATTACTCCAGCTGACAAGAGTTCCATCTTT-
IBFQ-3’ and a LightCycler 96 System (Roche Applied
Science, Mannheim, Germany). The reaction mixture
contained 1x Premix Ex Taq (Probe qPCR), 0.3 μM of
each primer, 0.1 μM of probe, 6.4 μl of nuclease free
water, and 2 μl of cDNA template or standard. The
cDNA template was generated as aforementioned.
The reaction was subjected to thermal cycling at 95 °
C for 30 s followed by 50 cycles of 95 °C for 5 s and
56 °C for 30 s.
Genome sequencing
Four complete genomes of ERBVs (strains 303, 396, 421
and 1228), including the full 5’-UTR regions, were amp-
lified and sequenced using strategies we previously used
for complete genome sequencing of other picornavi-
ruses, with the RNA extracted from the fecal samples as
templates [17, 39, 40, 42–44, 48–52]. The RNA was con-
verted to cDNA by a combined random-priming and
oligo (dT) priming strategy. The cDNA was amplified by
degenerate primers designed by multiple alignment of
the genomes of ERBV1 and ERBV2 (GenBank accession
no. NC_003983.1 and AF361253.1), and additional
primers designed from the results of the first and subse-
quent rounds of sequencing. The 5’ ends of the viral ge-
nomes were confirmed by rapid amplification of cDNA
ends using the SMARTer RACE cDNA Amplification
Kit (Clontech, USA). Sequences were checked manually
and assembled to produce final sequences of the full
viral genomes.
Genome analysis
Nucleotide sequences of the genomes and deduced
amino acid sequences of the encoded polyproteins were
compared to those of other picornaviruses. Unrooted
phylogenetic tree of 5’-UTR was constructed using
neighbor-joining method for aligned nucleotide se-
quences in ClustalX 2.1. Maximum-likelihood phylogen-
etic trees of P1, VP1, P2 and P3 were constructed using
PhyML 3.0 program [53] and Approximate Likelihood-
Ratio Test (aLRT) method [54]. Secondary structure pre-
diction in the 5’-UTR was performed using RNAstruc-
ture Web Server on strain 303 [55].
Estimation of synonymous and non-synonymous substitu-
tion rates
The number of synonymous substitutions per synonym-
ous site, Ks, and the number of non-synonymous substi-
tutions per non-synonymous site, Ka, for each coding
region among the three strains of ERBV3 were calcu-
lated using KaKs_Calculator 2.0 [56].
Estimation of divergence dates
The tMRCA was estimated based on an alignment of
VP1 sequences, using the UCLD in BEAST version 1.8
(http://beast.bio.ed.ac.uk/) [23]. Sampling dates of all
strains were collected from the literature or from the
present study, and were used as calibration points. Se-
quences were aligned according to the codon positions.
Depending on the data set, Markov chain Monte Carlo
(MCMC) sample chains were run for 2 × 107 states, sam-
pling every 1000 generations under the HKY/SRD06
model of substitution. A constant population coalescent
prior was assumed for all data sets. The median and
HPD were calculated for each of these parameters from
four identical but independent MCMC chains using
TRACER 1.3 (http://beast.bio.ed.ac.uk). The tree was an-
notated by TreeAnnotator, a program of BEAST and dis-
played by FigTree (http://tree.bio.ed.ac.uk/software/
figtree/).
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